[Translation] A randomized, double-blind, parallel-controlled, multicenter phase Ⅱb clinical study to evaluate the efficacy and safety of Shangganqingre oral liquid in the treatment of common cold (wind-heat syndrome)

评价上感清热口服液治疗普通感冒（风热证）的改善症状、缩短病程，以及改善中医证候作用，为Ⅲ期临床试验提供依据。(2)观察上感清热口服液临床应用的安全性。

[Translation]

To evaluate the effect of Shanggan Qingre Oral Liquid in improving symptoms, shortening the course of disease, and improving TCM syndromes in the treatment of common cold (wind-heat syndrome), and to provide a basis for Phase III clinical trials. (2) To observe the safety of Shanggan Qingre Oral Liquid in clinical application.

Start Date08 Apr 2025

Sponsor / Collaborator

Xi'an Shangyikang Medical Research Institute

CTR20191753

/ CompletedPhase 2

上感清热口服液治疗普通感冒（风热证）评价其有效性和安全性的随机、双盲、剂量探索、多中心Ⅱ期临床研究

[Translation] A randomized, double-blind, dose-finding, multicenter phase II clinical study to evaluate the efficacy and safety of Shangganqingre oral liquid in the treatment of common cold (wind-heat syndrome)

（1）初步评价上感清热口服液治疗普通感冒（风热证）的缩短病程、改善病情/症状，以及改善中医证候作用，并探索最佳剂量。（2）观察上感清热口服液临床应用的安全性。

[Translation]

(1) To preliminarily evaluate the efficacy of Shanggan Qingre Oral Liquid in shortening the course of the common cold (wind-heat syndrome), improving the condition/symptoms, and improving TCM syndromes, and to explore the optimal dose. (2) To observe the safety of Shanggan Qingre Oral Liquid in clinical application.

Start Date10 Jul 2023

Sponsor / Collaborator

Xi'an Shangyikang Medical Research Institute

100 Clinical Results associated with Shanggan Qingre Oral Liquid

100 Translational Medicine associated with Shanggan Qingre Oral Liquid

100 Patents (Medical) associated with Shanggan Qingre Oral Liquid

100 Deals associated with Shanggan Qingre Oral Liquid

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Common Cold	Phase 2	China	Xi'an Shangyikang Medical Research Institute	10 Jul 2023
Cough	Phase 2	China	Xi'an Shangyikang Medical Research Institute	10 Jul 2023
Fever	Phase 2	China	Xi'an Shangyikang Medical Research Institute	10 Jul 2023
Headache	Phase 2	China	Xi'an Shangyikang Medical Research Institute	10 Jul 2023
Nasal Obstruction	Phase 2	China	Xi'an Shangyikang Medical Research Institute	10 Jul 2023
Pharyngitis	Phase 2	China	Xi'an Shangyikang Medical Research Institute	10 Jul 2023
Xerostomia	Phase 2	China	Xi'an Shangyikang Medical Research Institute	10 Jul 2023

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis


No Data

Shanggan Qingre Oral Liquid

Overview

Basic Info

Related

R&D Status

Clinical Result

Translational Medicine

Deal

Core Patent

Clinical Trial

Approval

Regulation